No doubt they have cash flow, but don't see how a medical company in the testing business can continuously tweet about new sales everyday and is further behind in their filings than ALKM yet gets away with tweeting sales numbers all the time., but ALKM gets in trouble. A few 8Ks with sales numbers would be great.
The deal is structured as an assumption of the operations of Bell via an initial 5-year lease of the manufacturing facility at market rates, and a 5-year lease of the manufacturing equipment for $1.00 per year with an option to purchase at the end of the lease.
The option to purchase is for the manufacturing equipment. The manufacturing facility is leased at market rates for 5 years.
The statement can be misleading if you don't read carefully.